Data access to medicinal products for human use - Chapter 5 Annex A: Product data elements accessible by stakeholder group

Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2026

Human medicines European public assessment report (EPAR): Soliris, eculizumab, Date of authorisation: 20/06/2007, Revision: 41, Status: Authorised

Agenda of the CAT meeting 18-20 February 2026

Vaccine Monitoring Platform: List of EMA-funded studies

Trulicity

ACT EU multi-stakeholder platform annual meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 29 October 2025, 09:30 (CET) to 29 October 2025, 17:00 (CET)

Scientific advice and protocol assistance adopted during the CHMP meeting 26-29 January 2026

Human medicines European public assessment report (EPAR): Bronchitol, mannitol, Date of authorisation: 13/04/2012, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Trecondi, treosulfan, Date of authorisation: 20/06/2019, Revision: 6, Status: Authorised